Hard to see them pursuing it early unless they went with a DoD grant and a small trial. The issue is money and energy that is taken away from the current phase 3.
If they manage something - well much more of course - who knows. TBI seems to interest the market more than headaches.
What I think is possible/likely is that some preliminary work is done for TBI on the cheap, and as the readout to P3 approaches (aka like NEU), a cap raise is done. The company hedges itself on failure and can pursue TBI, if IIH is a flop.
Hard to see them pursuing it early unless they went with a DoD...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.6¢ |
Change
0.006(7.50%) |
Mkt cap ! $6.463M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.6¢ | 7.1¢ | $5.611K | 73.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60000 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.0¢ | 126146 | 1 |
View Market Depth
| Last trade - 14.30pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.006 ( 2.47 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 7.9¢ | 7.8¢ | 97853 | ||
| Last updated 14.27pm 06/05/2024 ? | |||||
| IXC (ASX) Chart |